Serum beta-glucuronidase levels in children with leprosy
Author(s) -
Devki Nandan,
K Venkatesan,
Kiran Katoch,
Rajeshwar Dayal
Publication year - 2007
Publication title -
leprosy review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 43
eISSN - 2162-8807
pISSN - 0305-7518
DOI - 10.47276/lr.78.3.243
Subject(s) - leprosy , medicine , pathogenesis , glucuronidase , beta (programming language) , immunology , beta glucuronidase , regimen , enzyme , lepromatous leprosy , biology , biochemistry , gene expression , computer science , gene , programming language
A study was undertaken to find out the usefulness of determining the circulating levels of beta-glucuronidase, a lysosomal enzyme in leprosy affected children of less than 15 years of age. The serum enzyme levels were significantly higher in BB/BL patients compared to healthy control children as well as children with skin diseases other than leprosy. Treatment with Multidrug regimen advocated by WHO for multi/paucibacillary leprosy resulted in a significant fall in the serum enzyme levels in BB and BL cases. The findings suggest that serum beta-glucuronidase may be a useful parameter for the activity and extent of pathogenesis in leprosy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom